Shareholders meeting

@ GRANULES Date: July 15, 2026 National Stock Exchange of India Limited & BSE Limited. Scrip Code: NSE- GRANULES; BSE-532482. Sub: Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements),Regulations 2015- Submission of Annual Report for the FY 2025-26. Dear Sir/Mam, Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the soft copy of the Integrated Annual Report of the Company for the financial year 2025-26 along with Notice of the 35" Annual General Meeting of the Company scheduled Thursday, August 06, 2026 at 11.30 a.m. (IST) to be held through Video Conferencing (“VC”). The aforementioned documents are available on the Company's website —at https:/granulesindia.com/. They are being sent to all members of the Company whose email IDs are registered with the Company or the Depositories. In addition, pursuant to Regulation 36 (1) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a letter is also being sent to the members whose email addresses are not registered, providing the web-link where the Integrated Annual Report is uploaded. ‘We request you to take the above information on record. Thanking You. For GRANULES INDIA LIMITED CHAITANYA TUMMALA (COMPANY SECRETARY & COMPLIANCE OFFICER) Encl: As above REGISTERED OFFICE Granules India Limited CIN: L24110TG1991PLC012471 15t Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad - 500084, Telangana, India Contact Us: Tel: +9140 69043500 | Fax: +91-40-23115145 | mail@granulesindia.com wwwigranulesindla.com Where strategy meets Evolving Healthcare Needs, Science & Sustainability. Granules India Limited Integrated Annual Report FY 2025-26 Navigate the pages About the Report 04-63 172-282 We are pleased to present the Integrated Our Six Capitals This Report adheres to the Global Annual Report of Granules India Limited Reporting Initiative (GRI) 2021 standards Corporate Overview Statutory Reports We follow a multi-capital approach for FY 2025-26. This Report provides and aligns with the Task Force on aligned with the IIRC framework. About Us 04 Business Responsibility and a comprehensive overview of how Climate-Related Financial Disclosures These six capitals form the foundation Management’s Message 08 Sustainability Report 172 we continue to drive value creation of our integrated thinking and value (TCFD) recommendations. Milestones 10 Management Discussion across our pharmaceutical value chain, creation strategy The GRI Framework provides a Our Sustainability Journey 12 and Analysis 232 while advancing sustainable, ethical comprehensive structure for disclosing Global Presence 14 Board’s Report 242 and responsible growth. The Report Financial our sustainability performance, enhancing Environmental Landscape 18 Corporate Governance Report 262 reflects our continued commitment to Capital the Report’s global relevance. Integrating Business Overview 20 transparency, governance and resilience TCFD elements, especially in the risk Business Strategy 22 283-420 in an evolving global environment. Manufactured assessment section, underscores Granules’ commitment to achieving net Business Model 28 Capital Financial Statements Our Reporting Framework zero emissions by 2050, with climate Materiality Assessment 30 Stakeholder Engagement 32 P16 This Report has been prepared in Intellectual action being a strategic priority. Standalone Risk Management 36 Financial Statements 283 Read more accordance with the guiding principles Capital We have mapped our initiatives Governance 44 Consolidated Responding to the of the International Integrated to the United Nations Sustainable Pulse of Healthcare Human Awards and Recognition 60 Financial Statements 345 Reporting Framework (IIRC) developed Development Goals (UNSDGs) and are Notice 413 by the International Integrated Capital proud signatories of the United Nations Reporting Council (IIRC). It explains Global Compact (UNGC). We also 64-165 Social and how sustainability and operational follow the Sustainability Accounting Relationship Capital Capital Overview 421-453 excellence are embedded in our Standards Board (SASB) guidelines Annexures business model to create long-term Natural for Biotechnology & Pharmaceuticals, Financial Capital 64 ensuring industry-specific disclosures. value for all stakeholders. The statutory Capital Manufactured Capital 68 GHG Report 421 disclosures align with applicable These frameworks support our broader Intellectual Capital 76 P26 sustainability strategy and demonstrate ESG Performance Table 425 Read more regulatory and financial reporting Human Capital 84 our commitment to tackling pressing UNGC Index 430 Advancing Care Through requirements, including: Reporting Scope and Boundary Social and Relationship Capital 102 global challenges. GRI Index 431 Purpose-Driven Science Natural Capital 134 Independent Assurance The Companies Act, 2013 This Report covers the operations of Granules India Limited, including External Assurance Statement for BRSR and GRI 437 Indian Accounting its domestic and international Sustainability Insights Across Standards (Ind AS) manufacturing facilities, R&D centres, This Integrated Report has undergone Granules’subsidiaries 166 external assurance for FY 25-26. The SEBI (Listing Obligations and and marketing offices. Information assurance was conducted by Bureau pertaining to subsidiaries and joint Disclosure Requirements) Veritas (India) Pvt. Ltd for the full fiscal ventures is included wherever relevant. Regulations, 2015 year, and We verified the reliability and Any exceptions or exclusions are clearly Where strategy meets P134 Secretarial Standards issued by ICSI stated in the respective sections accuracy of our data following GRI Evolving Healthcare Read more guidelines, using specific assumptions Needs, Science & Sustainability. Our Report's Cover Environmental Forward-looking Statements The disclosures and performance related and methodologies outlined in the landscape to environmental and social indicators Report. Details of the assurance level This year’s Integrated Annual Report, This Report contains certain forward- covered under Human Capital, Social and the type of assurance obtained are “Where Strategy Meets Evolving looking statements regarding Granules and Relationship Capital, and Natural provided in the respective sections. The Healthcare Needs, Science & India’s future performance, strategy Capital , as well as the Business GRI has also been notified regarding Sustainability,” reflects Granules India’s and outlook. Words such as ‘expects’, Responsibility and Sustainability Report the application of its standards in continued transformation into a science ‘intends’, ‘plans’, ‘believes’, ‘may’, ‘will’, (BRSR), are presented on a standalone preparing this Report. led, globally competitive pharmaceutical and other similar expressions are used basis for Granules India Limited. Key company. The cover symbolises to denote such statements. These are environmental and social performance Feedback our purpose of improving lives by GInrtaenguraletse dIn Adnian Luiaml Riteepdo rt FY 2025-26 based on present assumptions and information related to the Company’s Granules is committed to transparency responding to changing healthcare P Re4 a4 d more involve risks and uncertainties. Actual subsidiaries is disclosed separately in and stakeholder engagement, and needs through innovation, quality and The report highlights our progress results may differ materially. the relevant sections of this report. we consider feedback an essential in expanding complex generics, Governance sustainable growth. part of improving our disclosures. strengthening regulatory excellence, Reporting period, frequency Reporting Standards For any queries or suggestions The rising sun represents new advancing peptide therapeutics, related to this report or our ESG This Integrated Report covers the [Showing first 8,000 characters — download PDF for full document]